RUBELLA IN
PREGNANCY
Paryanto
Departement of Obstetrics and
Gynecology Faculty of Medicine
J a m b i University
CONGENITAL RUBELLA
• Rubella is a teratogenic virus
• Congenital rubella syndrome (CRS) occur
during the US rubella epidemic of 1964
• The fetus is at risk of CRS only during
primary infection
• Possibilities fetal infection occurs during
first 4 weeks after conception 61%, 5-8 w:
26%; 9-12 w: 8%; after 12 w: <5%
CONGENITAL RUBELLA
SYNDROME
• The most common abnormalities
associated with 1st trim infection are:
hearing loss in 60%-755%; eye defect:
50-90%%; heart disease: 40-85%;
psychomotor retardation: 25-40%
• Other abnormalities are: IUGR,
hepatosplenomegaly
• Less frequent: thrombocytopeni,
meningoencephalities
EPIDEMIOLOGY
• Also called German measles, caused by
rubella virus
• Minor infections in the absence of
pregnancy
• During pregnancy directly responsible for
inestimable wastage, as well as for severe
congenital malformation
Continue
• Transmission from direct contact with the
nasopharyngeal secretion of an infected
person
• The most contagious periode is the few
days before the onset of a maculopapuler
rash
• The incubation period range 14 – 21 days
MATERNAL INFECTION
• Symptomatic in 50%-70%
• Mild, maculopapular rash for 3 days
• Low fever, headache, loss of appetide,
and sore throat
• Generalized lymphadenopathy (especially
postauricular, occipital)
• Transient arthritis
FETAL INFECTION
• At least 50% infected fetuses when primary
maternal infection occurs in the 1st trim, when
the greatest risk of congenital anomalies exiests
• Multiple organ system involvement
• Permanent congenital defect: cataracts,
microphthalmia, glaucoma, PDA, pulmonary
artery stenosis, atrioventricular septal defect,
deafness, microcephaly, encephalopathy,
mental retardition and motor impairement
Continue
• One third of infant asymptomatic at birth
may develop late manifestation, including
diabetes mellitus, thyroid disorders, and
precocious puberty
• Mortality
• Spontaneous abortion 4-9%, stillbirth 2-3%
• Overall mortality of infant with congenital
rubella syndrome is 5-35%
DIAGNOSIS
• Serology, because viral isolation
technically difficult, result of tissue culture
take up 6 weeks
• Antibody detection methods
hemagglutination inhibition, RIA latex
agglutination
• Fourfold or greater increase in titer or
seroconversion indicates acute infection
Continues
• If seropositive on the first titer, no risk to
the fetus
• Primary rubella confers lifelong immunity
however may be incomplete
• Antirubella IgM can be found in both
primary and reinfection rubella
• Reinfection rubella usually is subclinical,
rarely is associated with viremia
PRENATAL DIAGNOSIS
• Identification IgM in fetal blood by direct
puncture under US guidance at 22 weeks
of gestation or later
• The presence of rubella specific IgM
antibody in blood obtain by cordocentesis
indicates congenital rubella infection,
because IgM does not cross the placenta
MANAGEMENT
• Pregnant women should undergo rubella
serum evaluiation
• A clinical hystory of rubella unreliable
• If the patient is nonimmune, she should
receive rubella vaccine after delivery
• Contraception should be used for a
minimum 3 months after vaccination
• Theoretical risk of teratogenecity if vaccine
is used during pregnancy
Continue
• If pregnant women is exposed to rubella,
immediate serologic evaluation
• If primary rubella is diagnosed, the mother
should be informed about the implications
of the infection for the fetus
• If acute infection is diagnosed during the
first trim, the option of therapeutic abortion
shoud be considered